Jade Biosciences, Inc. (JBIO)
16.57
+0.17
(+1.04%)
USD |
NASDAQ |
Nov 11, 16:00
16.57
0.00 (0.00%)
After-Hours: 17:33
Jade Biosciences Total Liabilities (Quarterly) : 32.20M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.20M |
| March 31, 2026 | 22.97M |
| December 31, 2025 | 17.26M |
| September 30, 2025 | 23.10M |
| June 30, 2025 | 22.41M |
| March 31, 2025 | 2.487M |
| December 31, 2024 | 3.898M |
| September 30, 2024 | 10.47M |
| June 30, 2024 | 17.30M |
| March 31, 2024 | 15.92M |
| December 31, 2023 | 17.96M |
| September 30, 2023 | 15.15M |
| Date | Value |
|---|---|
| June 30, 2023 | 13.83M |
| March 31, 2023 | 11.30M |
| December 31, 2022 | 8.558M |
| September 30, 2022 | 8.518M |
| June 30, 2022 | 4.631M |
| March 31, 2022 | 5.052M |
| December 31, 2021 | 2.945M |
| September 30, 2021 | 4.277M |
| June 30, 2021 | 4.193M |
| March 31, 2021 | 1.782M |
| December 31, 2020 | 1.774M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
| Vericel Corp. | 132.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.11M |
| Shareholders Equity (Quarterly) | 439.92M |
| Debt to Equity Ratio | 0.0014 |
| Current Ratio | 14.93 |
| Net Debt Paydown Yield | 0.00% |